Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSIG Regulatory News (SHI)

Share Price Information for SIG (SHI)

Share Price is delayed by 15 minutes
Get Live Data
7.89    -0.31 (-3.78%)
Bid:
7.97
Ask:
8.20
Spread: 0.23 (2.886%)
Market Cap: £91.19m
SHI Live PriceLast checked at - London Stock Exchange

Intraday SIG Share Chart

Trading Update

24 Jun 2024 07:00

RNS Number : 4905T
SIG PLC
24 June 2024
 

 

24 June 2024

SIG plc: Trading Update

 

SIG plc ("SIG", or "the Group"), a leading supplier of specialist insulation and building products across Europe, issues a trading update for the year ending 31 December 2024 to date.

 

Key points

· Market conditions have remained challenging, with Group like-for-like1 ("LFL") sales decline vs prior year in May and June to date at c7%, which is similar to that seen in the first four months of the year, but behind expectations.

· Given the weaker than expected trading in recent weeks and a consequently more cautious view of the timing of any potential market improvements during H2, the Board now expects our 2024 full year underlying operating profit2 to be in the range £20m-£30m, which is below the current analyst range.3

· The Group continues to perform well relative to its markets and is also continuing to drive cost reductions and efficiency initiatives, which support the continued expectation of a stronger second half performance and will help drive higher profitability as markets recover.

· Cash performance to date remains in line with expectations.

 

Summary

Subdued demand has continued to be a factor in the majority of the Group's markets, reflecting the ongoing softness in the building and construction sector. This impact has been most notable in the French and German markets, and in the end markets of our UK Interiors business. Whilst we continue to see more robust demand in our Poland, Ireland and UK Exteriors businesses, Group sales overall were weaker than expected in May and June to date.

 

Despite the difficult market backdrop, the Group continues to make good progress on its strategic and operational initiatives. These have included permanent cost restructuring to lower central and operating company overheads, modernisation implementations which will lower our cost-to-serve and support higher margin sales mix, and more robust commercial execution, which has seen a continuation of the market share growth achieved over the last three years. The Group also continues to prioritise and demonstrate effective working capital and cash flow management, with year to date cash performance also reflecting normal seasonal trends and the lower profit, and our RCF remaining undrawn.

 

Outlook

Based on the performance in the year to date, the Board now expects the Group to report an H1 2024 LFL sales decline of c7%, and an underlying operating profit in the range of £10m-£12m. Given the weaker than expected trading in recent weeks and a consequently more cautious view of the timing of any potential market improvements during H2, the Board now expects our full year 2024 underlying operating profit to be in the range of £20m-£30m, which is below the current analyst range. The increasing benefit from productivity and cost initiatives underpins our continued expectation of a stronger second half. The extent of this improvement is subject to the evolution of demand conditions, particularly given market uncertainties in France and Germany, and recognising the sensitivity of operating profit to relatively small movements in sales.

 

Whilst market conditions remaining challenging in a majority of areas, the Board continues to expect its strategic and commercial initiatives to benefit medium term margin and profit growth, also supported by meaningful operating leverage when market volumes recover.

 

 

H1 Results

We will publish the Group's H1 2024 results on 6 August 2024, with a presentation and conference call for analysts at 10.15am at the offices of FTI Consulting.

 

1. Like-for-like is defined as sales per working day in constant currency, excluding completed acquisitions and disposals. It does not reflect adjustments for branch closures, openings, or consolidations.

2. Underlying represents the results before Other items. Other items relate to the amortisation of acquired intangibles, impairment charges, profits and losses on agreed sale or closure of non-core businesses and associated impairment charges, net operating profits and losses attributable to businesses identified as non-core, net restructuring costs, and other non-underlying profits or losses.

3. Company collated analyst expectations is for Full Year 2024 underlying operating profit (EBIT) of £41.1m, within a range of £36.7m to £43.0m, as at 21 June 2024.

 

 

Contacts

SIG plc

 

+44 (0) 114 285 6300 / ir@sigplc.com

Gavin Slark

Ian Ashton

Chief Executive Officer

Chief Financial Officer

 

Sarah Ogilvie

Head of Investor Relations

FTI Consulting

 

+44 (0) 20 3727 1340

Richard Mountain

LEI: 213800VDC1BKJEZ8PV53

 

This announcement contains inside information for the purposes of UK MAR. The person responsible for arranging the release of this announcement on behalf of SIG is Andrew Watkins, Group General Counsel & Company Secretary.

 

Cautionary Statement

This document contains certain forward-looking statements concerning the Group's business, financial condition, results of operations and certain Group's plans, objectives, assumptions, projections, expectations or beliefs with respect to these items. Forward-looking statements are sometimes, but not always, identified by their use of a date in the future or such words as 'anticipates', 'aims', 'due', 'could', 'may', 'will', 'would', 'should', 'expects', 'believes', 'intends', 'plans', 'potential', 'targets', 'goal', 'forecasts' or 'estimates' or similar expressions or negatives thereof.

 

Forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the Group's actual financial condition, performance and results to differ materially from the plans, goals, objectives and expectations set out in the forward-looking statements included in this document.

 

All written or verbal forward-looking statements, made in this document or made subsequently, which are attributable to the Group or any persons acting on its behalf are expressly qualified in their entirety by the factors referred to above. Accordingly, readers are cautioned not to place undue reliance on forward-looking statements. No assurance can be given that the forward-looking statements in this document will be realised; actual events or results may differ materially as a result of risks and uncertainties facing the Group. Subject to compliance with applicable law and regulation, the Group does not intend to update the forward-looking statements in this document to reflect events or circumstances after the date of this document and does not undertake any obligation to do so.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUOORRSKUNUUR
Date   Source Headline
25th Feb 201610:12 amRNSDirector Declaration
23rd Feb 201610:31 amRNSHome Member State
18th Feb 20166:14 pmRNSHolding(s) in Company
16th Feb 201612:11 pmRNSDirector/PDMR Shareholding
4th Feb 20168:47 amRNSBlocklisting Interim Review
18th Jan 20169:16 amRNSHolding(s) in Company
15th Jan 20164:11 pmRNSDirector/PDMR Shareholding
15th Jan 20169:06 amRNSHolding(s) in Company
14th Jan 20167:00 amRNSTrading Update
13th Jan 20162:13 pmRNSHolding(s) in Company
13th Jan 20169:09 amRNSHolding(s) in Company
11th Jan 20165:27 pmRNSHolding(s) in Company
11th Jan 20163:46 pmRNSHolding(s) in Company
7th Jan 20167:00 amRNSNotification of Trading Statement
4th Jan 20168:29 amRNSTotal Voting Rights
21st Dec 20154:30 pmRNSHolding(s) in Company
15th Dec 20154:19 pmRNSDirector/PDMR Shareholding
8th Dec 20159:11 amRNSHolding(s) in Company
4th Dec 201511:58 amRNSDirector/PDMR Shareholding
1st Dec 20159:01 amRNSHolding(s) in Company
1st Dec 20158:50 amRNSTotal Voting Rights
30th Nov 20159:42 amRNSHolding(s) in Company
25th Nov 20154:06 pmRNSHolding(s) in Company
17th Nov 201511:00 amRNSDirector/PDMR Shareholding
17th Nov 20159:29 amRNSDirector/PDMR Shareholding
17th Nov 20159:28 amRNSDirector/PDMR Shareholding
17th Nov 20159:27 amRNSDirector/PDMR Shareholding
16th Nov 20157:00 amRNSCapital Markets Day and October Trading
13th Nov 20154:27 pmRNSHolding(s) in Company
2nd Nov 201510:51 amRNSTotal Voting Rights
26th Oct 201512:41 pmRNSDirector/PDMR Shareholding
26th Oct 201512:39 pmRNSDirector/PDMR Shareholding
23rd Oct 201511:26 amRNSHolding(s) in Company
22nd Oct 20157:00 amRNSTrading Statement
15th Oct 20154:34 pmRNSDirector/PDMR Shareholding
1st Oct 20159:10 amRNSTotal Voting Rights
30th Sep 201511:42 amRNSDirector/PDMR Shareholding
30th Sep 201511:40 amRNSDirector/PDMR Shareholding
18th Sep 20159:44 amRNSDirector/PDMR Shareholding
15th Sep 20154:04 pmRNSDirector/PDMR Shareholding
1st Sep 20159:42 amRNSTotal Voting Rights
25th Aug 201510:05 amRNSDirector/PDMR Shareholding
18th Aug 20154:57 pmRNSDirector/PDMR Shareholding
12th Aug 20153:36 pmRNSHolding(s) in Company
11th Aug 20157:00 amRNSHalf Yearly Report
7th Aug 201512:20 pmRNSHolding(s) in Company
4th Aug 20153:46 pmRNSBlocklisting Interim Review
16th Jul 201510:02 amRNSDirector/PDMR Shareholding
2nd Jul 20159:27 amRNSDirector Declaration - Replacement
2nd Jul 20158:47 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.